Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Intellivax International Inc.

Division of GlaxoSmithKline PLC
www.intellivax.com

Latest From Intellivax International Inc.

Biotechnology North of the Border

A venture-backed Canadian biotechnology industry is in its infancy, but faced with hostile capital markets, start-ups need clear exit plans. Consolidation's already started.
BioPharmaceutical Business Strategies

No More Ouch! Vaccine Delivery is Changing

Since the mid-1950's getting "shots" has been a source of childhood terror. Now, small companies are looking at ways to deliver vaccines through the oral or nasal mucosa, or using needle-free skin delivery systems to take advantage of immune cells within the skin.
BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • GlaxoSmithKline PLC
  • Senior Management
  • George Lowell, MD, CSO
  • Contact Info
  • Intellivax International Inc.
    Phone: (514) 334-0606
    5757 Cavendish Blvd. Cote St. Luc
    Montreal, H4W 2W8
    Canada
Advertisement
Advertisement
UsernamePublicRestriction

Register